drug
fostamatinib
updated 3mo agoby National Heart Lung and Blood Institute
community read0 votes
🐶 often sniffed alongside
top 7- drugImmunology1 co-mentions · 1 sources
- companyNational Heart Lung and Blood Institute1 co-mentions · 1 sources
- tagCardiology1 co-mentions · 1 sources
- tagPulmonology1 co-mentions · 1 sources
- tagImmunology1 co-mentions · 1 sources
- tagHematology1 co-mentions · 1 sources
- tagHepatology1 co-mentions · 1 sources
all catalysts(1)
Trials studying fostamatinib
- phase1Perioperative Fostamatinib With Gemcitabine and Nab-paclitaxel in Resectable Pancreatic Cancer
- phase2Fostamatinib for Treating Acute Respiratory Distress Syndrome (ARDS) in Hospitalized Adults
- phase1Ruxolitinib Plus Fostamatinib for Steroid Refractory cGvHD
- phase2Inflammatory Signal Inhibitors for COVID-19 (MATIS)
- —Special Drug Use-results Survey for Long-term Use (Fostamatinib)
- phase1Clinical Trial of Combined Fostamatinib and Paclitaxel in Ovarian Cancer
- —Observational Study of Fostamatinib as Second Line Therapy in Adult Patients With Immune Thrombocytopenia (ITP) and Insufficient Response to a Prior Therapy
- phase2Fostamatinib as a Single Agent or in Combination With Ruxolitinib for Treatment of Patients With Myelofibrosis With Severe Thrombocytopenia
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 1h ago
Found something off?
comments(0)
5-min edit window · permanent after that